Expression of miR-486 is a potential prognostic factor after nephrectomy in advanced renal cell carcinoma

By Goto  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 235-240

Spandidos Publications

Access to resources Recommend Favorite

Partial nephrectomy with in situ perfusion preservation for renal cell carcinoma in a long established renal transplant

By Merkel F.K.   Miller J.L.   Hibblen J.F.   Owens C.J.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2295-2297

Elsevier

Access to resources Recommend Favorite

Progress and potential of immune checkpoint blockade for treating advanced renal cell carcinoma

By Tykodi Scott S  

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 607-619

Future Medicine

Access to resources Recommend Favorite

Ideal Body Weight Predicts Remaining Renal Function Following Donor Nephrectomy

By Hakaim A.G.   Badgett D.   Carpinito G.   Mesler D.   Idelson B.   Liberthal W.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2781-2782

Elsevier

Access to resources Recommend Favorite

Successful treatment of erythropoietin-producing advanced renal cell carcinoma after targeted therapy using sunitinib: Case report and review of the literature

By Ueda   Suekane   Chikui   Nakiri   Moriya   Hayashi   Miyajima   Matsuoka  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 112-116

Spandidos Publications

Access to resources Recommend Favorite